These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29769949)

  • 1. Maintaining measles elimination in Canada: Moving forward.
    Lam P; Williams L; Gadient S; Squires S; St-Laurent M
    Can Commun Dis Rep; 2015 Jul; 41(7):175-178. PubMed ID: 29769949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles surveillance in Canada, 2019.
    Coulby C; Domingo FR; Hiebert J; Squires SG
    Can Commun Dis Rep; 2021 Mar; 47(3):149-160. PubMed ID: 34012339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
    Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles activity in Canada: January - June 2014.
    Deehan H; Shane A
    Can Commun Dis Rep; 2014 Jun; 40(12):233-235. PubMed ID: 29769845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documenting the elimination of measles, rubella and congenital rubella syndrome in Ontario: 2009-12.
    Lim GH; Deeks SL; Fediurek J; Gubbay J; Crowcroft NS
    Can Commun Dis Rep; 2014 Apr; 40(8):143-151. PubMed ID: 29769895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles resurgence in southern Africa: challenges to measles elimination.
    Shibeshi ME; Masresha BG; Smit SB; Biellik RJ; Nicholson JL; Muitherero C; Shivute N; Walker O; Reggis K; Goodson JL
    Vaccine; 2014 Apr; 32(16):1798-807. PubMed ID: 24530936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
    Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P; Jankovic D; Zimmerman L; Ben Mamou M; Reef S
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):833-839. PubMed ID: 34111057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress Toward Measles Elimination - Nepal, 2007-2014.
    Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles control in Australia - threats, opportunities and future needs.
    MacIntyre CR; Kpozehouen E; Kunasekaran M; Harriman K; Conaty S; Rosewell A; Druce J; Martin N; Heywood AE; Gidding HF; Wood J; Nicholl S
    Vaccine; 2018 Jul; 36(30):4393-4398. PubMed ID: 29934234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles surveillance in Canada: 2018.
    Coulby C; Domingo FR; Hiebert J; MacDonald D
    Can Commun Dis Rep; 2020 Apr; 46(4):77-83. PubMed ID: 32558823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles in adults in Canada and the United States: implications for measles elimination and eradication.
    Duclos P; Redd SC; Varughese P; Hersh BS
    Int J Epidemiol; 1999 Feb; 28(1):141-6. PubMed ID: 10195679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress of EPI programs reviewed in Central American and Andean regions.
    EPI Newsl; 1995 Oct; 17(5):3-5. PubMed ID: 12290577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles surveillance in Canada: 2015.
    Sherrard L; Hiebert J; Cunliffe J; Mendoza L; Cutler J
    Can Commun Dis Rep; 2016 Jul; 42(7):139-145. PubMed ID: 29770019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward measles elimination--Western Pacific Region, 2009-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(22):443-7. PubMed ID: 23739338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges of sustaining measles elimination in Canada.
    Crowcroft NS
    Can Commun Dis Rep; 2014 Jun; 40(12):261-264. PubMed ID: 29769850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles outbreaks: what does it represent for the elimination strategy in the region of the Americas? A call for the action.
    Avila-Aguero ML; Camacho-Badilla K; Ulloa-Gutierrez R
    Expert Rev Vaccines; 2015; 14(8):1043-5. PubMed ID: 26065443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.